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Intravascular cancer cell adhesion plays a significant role in the metastatic process. 
Studies indicate that galectin-3, a member of the galectin family of soluble animal lectins, 
is involved in carbohydrate-mediated metastatic cell heterotypic and homotypic  adhesion 
via interactions with the tumor-specific Thomsen-Friedenreich glycoantigen (TFAg). We 
hypothesized that the specific molecular inhibition of the interaction between galectin-3 
and its ligands would reduce carcinoma cell adhesion. To test this hypothesis, we 
identified peptide antagonists of galectin-3 using phage display technology. The peptides 
bound with high affinity to galectin-3 protein and to cell surface galectin-3. Further 
experiments indicated that the peptides bound the CRD of galectin-3. Moreover, the 
peptides did not bind the CRD of other galectins and plant lectins. Synthetic galectin-3 
CRD-specific peptides blocked the interaction between galectin-3 and TFAg and 
significantly inhibited heterotypic adhesion of human MDA-MB-435 breast carcinoma 
cells to endothelial cells under flow conditions, as well as homotypic tumor cell 
aggregation. These results demonstrate that carbohydrate-mediated metastasis-associated 
tumor cell adhesion could be inhibited efficiently with short synthetic peptides. 
We also investigated the possibility that galectin-3 specific phage would target to 
tumors highly expressing the protein in mice. The phage harboring galectin-3 binding 
peptides failed to exclusively target to human MDA-MB-435 breast tumor 
heterotransplanted in mice. However, the pharmacokinetic properties of random phage 
peptide display fd-tet libraries, in vivo, were fully investigated. This study will be 
extremely useful in the design of in vivo application strategies, especially in isolating 
tumor-avid molecules with a priori optimum in vivo properties 
 
